Role of Arginase in Impairing Relaxation of Lung Parenchyma of Hyperoxia-Exposed Neonatal Rats
- 23 September 2011
- journal article
- research article
- Published by S. Karger AG in Neonatology
- Vol. 101 (2), 106-115
- https://doi.org/10.1159/000329540
Abstract
Background: Prolonged exposure of immature lungs to hyperoxia contributes to neonatal lung injury and airway hyperreactivity. We have previously demonstrated that neonatal exposure of rat pups to ≧95% O2 impairs airway relaxation due to disruption of nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling. Objective: We now hypothesize that these impaired relaxation responses are secondary to hyperoxia-induced upregulation of arginase, which competes with NO synthase for L-arginine. Methods: Rat pups were exposed to moderate neonatal hyperoxia (50% O2) or room air for 7 days from birth. In additional hyperoxic and room air groups, exogenous L-arginine (300 mg/kg/day i.p.) or arginase inhibitor (Nω-hydroxy-nor-arginine, 30 mg/kg/day i.p.) were administered daily. After 7 days, animals were anesthetized and sacrificed either for preparation of lung parenchymal strips or lung perfusion. Results: In response to electrical field stimulation (EFS), bethanechol-preconstricted lung parenchymal strips from hyperoxic pups exhibited significantly reduced relaxation compared to room air controls. Supplementation of L-arginine or arginase blockade restored hyperoxia-induced impairment of relaxation. Expression of arginase I in airway epithelium was increased in response to hyperoxia but reduced by arginase blockade. Arginase activity was also significantly increased in hyperoxic lungs as compared to room air controls and reduced following arginase blockade. EFS-induced production of NO was decreased in hyperoxia-exposed airway smooth muscle and restored by arginase blockade. Conclusion: These data suggest that NO-cGMP signaling is disrupted in neonatal rat pups exposed to even moderate hyperoxia due to increased arginase activity and consequent decreased bioavailability of the substrate L-arginine. We speculate that supplementation of arginine and/or inhibition of arginase may be a useful therapeutic tool to prevent or treat neonatal lung injury.Keywords
This publication has 31 references indexed in Scilit:
- Neurotrophins induce nitric oxide generation in human pulmonary artery endothelial cellsCardiovascular Research, 2011
- Decreased Arginine Bioavailability and Increased Serum Arginase Activity in AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Hyperoxia impairs airway relaxation in immature rats via a cAMP-mediated mechanismJournal of Applied Physiology, 2004
- Chronic O2 exposure enhances vascular and airway smooth muscle contraction in the newborn but not adult ratJournal of Applied Physiology, 2003
- Increased arginase activity underlies allergen‐induced deficiency of cNOS‐derived nitric oxide and airway hyperresponsivenessBritish Journal of Pharmacology, 2002
- Prolonged Moderate Hyperoxia Induces Hyperresponsiveness and Airway Inflammation in Newborn RatsPediatric Research, 2001
- Role of endogenous nitric oxide in hyperoxia-induced airway hyperreactivity in maturing ratsJournal of Applied Physiology, 2000
- Structural and Functional Abnormalities of the Airways of Hyperoxia-Exposed Immature RatsChest, 1995
- Rat Mammary Arginase: Isolation and CharacterizationBiochemical Medicine and Metabolic Biology, 1994
- Nitric oxide as an endogenous modulator of cholinergic neurotransmission in guinea-pig airwaysEuropean Journal of Pharmacology, 1991